Skip to main content

Featured

Intel’s Weak Earnings Put Futures on Ice After a Choppy Week

U.S. stock futures lost momentum Friday morning as Wall Street tried to steady itself after several days of sharp swings. Dow futures slipped, while S&P 500 and Nasdaq futures hovered slightly lower, signaling a cautious start to the trading day. The hesitation came largely from Intel’s disappointing earnings report. The chipmaker’s results and weaker outlook weighed heavily on tech sentiment, sending its shares sharply lower in pre‑market trading. Investors had hoped for stronger numbers given the industry’s AI‑driven momentum, but Intel’s update suggested ongoing challenges in key segments like data‑center chips. The broader market has been wrestling with volatility all week, driven by shifting economic expectations and uneven corporate results. With the S&P 500 on track for another weekly decline, traders appear reluctant to make big moves until they see clearer signs of stability.
Post a Comment
Read more

article

Labels

Young-onset dementia: A growing public health concern in Canada

 

Young-onset dementia is a growing public health concern in Canada. According to the Alzheimer Society of Canada, the number of individuals impacted is projected to reach more than 40,000 people by 2050.

The diagnosis of dementia in individuals under the age of 65 is referred to as “young onset dementia” and poses unique challenges. Diagnoses are often delayed, and it’s tough to get workplace accommodations.

The reasons behind the rise of young-onset dementia in Canada are not yet fully understood. However, the latest landmark study by the Alzheimer’s Society of Canada suggests that a growing number of Canadians are developing dementia in their 60s, 50s, 40s, and even earlier. The study highlights that the initial diagnosis of young-onset dementia is often incorrect, leading to delayed diagnoses and missed opportunities for early intervention.


Labels:

Comments

Post a Comment